- Department of Neurosurgery, Fukui Prefectural Hospital, Fukui, Japan
Correspondence Address:
Keijiro Shomura, Department of Neurosurgery, Fukui Prefectural Hospital, Fukui, Japan.
DOI:10.25259/SNI_207_2025
Copyright: © 2025 Surgical Neurology International This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.How to cite this article: Keijiro Shomura, Katsuyoshi Miyashita, Seiya Kudo, Iku Nambu, Yasuo Tohma. Infratentorial cerebral proliferative angiopathy: A rare entity with high risk of hemorrhage. 30-May-2025;16:216
How to cite this URL: Keijiro Shomura, Katsuyoshi Miyashita, Seiya Kudo, Iku Nambu, Yasuo Tohma. Infratentorial cerebral proliferative angiopathy: A rare entity with high risk of hemorrhage. 30-May-2025;16:216. Available from: https://surgicalneurologyint.com/?post_type=surgicalint_articles&p=13588
Abstract
Background: Cerebral proliferative angiopathy (CPA) is a rare vascular disease characterized by nonfocal angiogenic activity. Numerous case reports have been published; however, despite there are a few reported cases of infratentorial CPA (or cerebellar proliferative angiopathy), no comprehensive review of this condition has been conducted.
Case Description: We report two cases of infratentorial CPA, and both of them presented intracranial hemorrhage. The first case was a 48-year-old woman with an incidentally detected vascular abnormality in the cerebellum, which remained stable for 11 years before presenting with subarachnoid hemorrhage. The second case was a 5-year-old girl who presented with a sudden headache and decreased consciousness. Digital subtraction angiography was performed in both cases, but the source of hemorrhage remained unidentified, and conservative management was chosen.
Conclusion: A review of previously reported infratentorial CPA cases suggests that infratentorial CPA has a significantly higher risk of hemorrhage than supratentorial CPA. However, the risk of rebleeding appears to be low. Our findings highlight the need for further research to determine the optimal management strategies for this rare entity.
Keywords: Cerebral proliferative angiopathy, Intracranial hemorrhages, Vascular disease
INTRODUCTION
Cerebral proliferative angiopathy (CPA) is a rare vascular brain abnormality distinct from classical arteriovenous malformations (AVMs).[
CASE REPORT
Patient 1
A 48-year-old woman underwent a routine brain health check-up, during which magnetic resonance imaging (MRI) incidentally detected abnormal angioarchitecture in the cerebellum [
Figure 1:
(a) Initial magnetic resonance imaging (MRI) obtained when patient 1 was 48 years old revealed abnormal vascular proliferation in the left cerebellar hemisphere. The MRI also showed dilation of the draining vein into the great vein of Galen. (b) Computed tomography performed 11 years later, following a severe headache episode, revealed a subarachnoid hemorrhage. (c) MRI at the time of subarachnoid hemorrhage. Vascular structures showed no significant changes compared to the findings 11 years earlier.
Figure 2:
(a) Left vertebral angiogram revealed densely proliferated abnormal vessels throughout the left cerebellar hemisphere, draining into an enlarged great vein of Galen. No dominant feeder was identified. (b) Left external carotid angiogram demonstrated transdural supply from the occipital and middle meningeal arteries. (c) Posterior oblique view of three-dimensional rotational angiography revealed no aneurysms or dissections. Numerous abnormal vessels were observed in the left cerebellar hemisphere.
Patient 2
A 5-year-old girl presented to our hospital with a sudden headache and deteriorating consciousness. CT revealed a left cerebellar hemorrhage [
Figure 4:
(a) Digital subtraction angiography of patient 2 showed numerous small feeders originating from the left superior cerebellar artery and posterior inferior cerebellar artery with no identifiable dominant feeder or draining vein. (b) Three-dimensional rotational angiography was performed to identify the source of bleeding, but no clear evidence of an aneurysm or dissection was observed.
DISCUSSION
Numerous case reports and reviews on CPA have been published. According to the latest systematic review, which primarily included supratentorial CPA, the mean age of discovery of CPA was 26.9 years, with 58% of cases occurring in females, indicating a higher prevalence in young women.[
CPA is thought to be caused by reactive angiogenesis in response to ischemia.[
Among our two cases, the 48-year-old female patient is particularly significant because of the exceptionally long follow-up period of 19 years, providing valuable insights into the clinical course before and after hemorrhage. Hemorrhage occurred 11 years after the initial detection, with no re-bleeding observed over the subsequent 8 years. This case represents the longest observation period for hemorrhagic infratentorial CPA and suggests that hemorrhage may occur several years after initial detection. Furthermore, a review of previously reported cases suggests that hemorrhage in infratentorial CPA can occur across a wide range of age groups. The 5-year-old patient represents the youngest reported case of infratentorial CPA presenting with hemorrhage. These findings highlight the importance of recognizing the risk of hemorrhage regardless of age.
Various treatment approaches, including endovascular therapy, surgical resection, radiosurgery, revascularization, and conservative management, have been used for CPA.[
CONCLUSION
Our findings suggest that infratentorial CPA may have a distinct natural history compared to supratentorial CPA, with a significantly higher risk of hemorrhage but a low risk of rebleeding. Further research is needed to elucidate the underlying causes of hemorrhage and develop effective treatment strategies.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent.
Financial support and sponsorship:
Nil.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that they have used artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript or image creations.
Disclaimer
The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Journal or its management. The information contained in this article should not be considered to be medical advice; patients should consult their own physicians for advice as to their specific medical needs.
References
1. Beniwal M, Kandregula S, Aravind , Rao KV, Vikas V, Srinivas D. Pediatric cerebral proliferative angiopathy presenting infratentorial hemorrhage. Child’s Nerv Sys. 2020. 36: 429-33
2. Brake A, Fry L, Chatley KS, Peterson J, Stepp T, Wang F. Volume staged stereotactic radiosurgery and endovascular embolization in the treatment of cerebral proliferative angiopathy: Lessons learned. Br J Neurosurg. 2021. 38: 1047-51
3. Brown NJ, Lien BV, Ehresman J, Rahmani R, Catapano JS, Lawton MT. Proliferative angiopathy: A systematic review. Stroke Vasc Interv Neurol. 2024. 4: e001186
4. Giragani S, Pavunesan SK, Balasubramaniam A. Targeted endovascular treatment of haemorrhagic posterior fossa proliferative angiopathy. Interv Neuroradiol. 2018. 24: 440-3
5. Kumar S, Sharma M, Srivastava T, Sinha VD. Infratentorial hemorrhagic cerebral proliferative angiopathy: A rare presentation of a rare disease. Asian J Neurosurg. 2015. 10: 240-2
6. Lasjaunias PL, Landrieu P, Rodesch G, Alvarez H, Ozanne A, Holmin S. Cerebral proliferative angiopathy: Clinical and angiographic description of an entity different from cerebral AVMs. Stroke. 2008. 39: 878-85
7. Liu P, Lv X, Lv M, Li Y. Cerebral proliferative angiopathy: Clinical, angiographic features and literature review. Interv Neuroradiol. 2016. 22: 101-7
8. Ochoa A, Mantese B, Requejo F. Hemorrhagic cerebral proliferative angiopathy in two pediatric patients: Case reports. Childs Nerv Syst. 2022. 38: 789-94
9. Palavani LB, Mitre LP, Almeida MV, Neto LB, Ferreira MY, Semione G. Presentation and management of cerebral proliferative angiopathy: A systematic review and meta-analysis on treatment outcomes. Neurosurg Rev. 2024. 47: 664
10. Vilela MD, Tazinaffo U. Cerebellar proliferative angiopathy associated with a pontine telangiectasia and a developmental venous anomaly. World Neurosurg. 2018. 114: 106-10
11. Yamaki VN, Solla DJ, Telles JP, Liem GL, Da Silva SA, Caldas JG. The current clinical picture of cerebral proliferative angiopathy: Systematic review. Acta Neurochir (Wien). 2020. 162: 1727-33